United States · FDA National Drug Code directory
Carglumic acid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 35573-459_28393de7-fa10-4e7d-919e-4d0b19c888a1
- Product NDC
- 35573-459
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- Carglumic acid
- Labeler
- Burel Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221219
- Source listing expiry
- 20261231
Source-listed ingredients
- CARGLUMIC ACID — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FOR SUSPENSION in 1 BOTTLE (35573-459-60) · 35573-459-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →